Clinical Investigation

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.
Clinical Trials in Brazil

Clinical Investigation

Clinical Investigation in Brazil – Full Service CRO

Clinical investigation, also known as clinical research, refers to the process of conducting experiments or trials on human subjects to develop and test new medical interventions, such as drugs, devices, or procedures. Brazil has become a hub for clinical investigation in recent years, with a growing number of companies and researchers choosing the country for their studies. 

In this blog post, we will explore the reasons why Brazil has become a popular destination for clinical investigation and some of the challenges that researchers face in conducting trials in the country.

One of the main reasons why Brazil has become a hub for clinical investigation is its large and diverse population. With over 213 million people, Brazil is the fifth most populous country in the world. The country also has a diverse mix of ethnicities and cultures, making it an ideal location for studying the impact of new medical interventions on different populations.

Brazil also has a well-developed healthcare system, with both public and private hospitals and clinics, providing access to a large pool of potential study participants.

Another advantage of conducting clinical investigation in Brazil is its favorable regulatory environment. The Brazilian National Health Surveillance Agency (ANVISA) is responsible for regulating clinical trials in the country and has implemented regulations that are in line with international standards. This makes it easier for companies and researchers to conduct trials in Brazil and obtain regulatory approval for their products.

Brazil also offers cost advantages for clinical investigation. Compared to other developed countries, the cost of conducting clinical trials in Brazil is relatively low. This is because labor costs and other expenses are lower in Brazil than in other developed countries. This makes Brazil an attractive location for companies and researchers looking to conduct trials on a budget.

Cohortias the CRO of LATAM
Clinical Investigation
Clinical Investigation

Brazil's Clinical Trial Industry

Despite these advantages, conducting clinical investigation in Brazil is not without its challenges. One of the biggest challenges is the complex and bureaucratic regulatory environment. Obtaining regulatory approval for clinical trials in Brazil can be a lengthy and complicated process, requiring multiple approvals from different agencies. This can lead to delays in the start of trials, which can be frustrating for researchers and companies.

Another challenge is the lack of infrastructure in some parts of the country. Although Brazil has a well-developed healthcare system, some rural areas lack the necessary infrastructure to support clinical trials. This can make it difficult to recruit participants from these areas, which can limit the generalizability of the study findings.

There are also concerns about the quality of data generated from clinical trials conducted in Brazil. Although Brazil has implemented regulations in line with international standards, there are concerns that some trials may not adhere to these standards. This can lead to issues with data quality and integrity, which can impact the credibility of the study findings.

In conclusion, Brazil has become a popular destination for clinical investigation due to its large and diverse population, favorable regulatory environment, and cost advantages. However, conducting trials in Brazil can be challenging due to the complex and bureaucratic regulatory environment, lack of infrastructure in some areas, and concerns about data quality. 

Researchers and companies looking to conduct clinical trials in Brazil need to be aware of these challenges and take steps to address them to ensure the success of their studies.

Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Cohortias the CRO of LATAM

Clinical Trials in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Investigation

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Investigation

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Investigation

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Investigation

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Investigation

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Investigation

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Investigation

The Cohortias Team

Clinical Investigation

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Investigation

Network & Partnerships